Optiver Holding B.V. Genfit S.A. Transaction History
Optiver Holding B.V.
- $2.48 Billion
- Q1 2025
A detailed history of Optiver Holding B.V. transactions in Genfit S.A. stock. As of the latest transaction made, Optiver Holding B.V. holds 13,155 shares of GNFT stock, worth $56,698. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,155
Previous 266
4845.49%
Holding current value
$56,698
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding GNFT
# of Institutions
9Shares Held
209KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny131KShares$566,6910.0% of portfolio
-
Morgan Stanley New York, NY25.5KShares$109,9910.0% of portfolio
-
Old Mission Capital LLC22.2KShares$95,8450.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.3KShares$53,1460.0% of portfolio
-
Ubs Group Ag3.12KShares$13,4380.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $215M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...